| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men
|
Firth, C.
|
|
|
54 |
C |
p.
|
artikel
|
| 2 |
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
|
Dowgier, Giulia
|
|
|
54 |
C |
p.
|
artikel
|
| 3 |
A gamma-irradiated pneumococcal vaccine elicits superior immunogenicity in comparison to heat or chemically inactivated whole-cell vaccines
|
Gates, Chloe J.
|
|
|
54 |
C |
p.
|
artikel
|
| 4 |
Antiviral humoral immunity against SARS-CoV-2 omicron JN.1 subvariants induced by JN.1 recombinant protein vaccine
|
Uriu, Keiya
|
|
|
54 |
C |
p.
|
artikel
|
| 5 |
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age
|
Hegmann, Theresa E.
|
|
|
54 |
C |
p.
|
artikel
|
| 6 |
Applying the health belief model (HBM) to understand COVID-19 vaccine uptake among youth and young adults: Findings from a 6-month follow-up study in the United States
|
Xu, Jiayi
|
|
|
54 |
C |
p.
|
artikel
|
| 7 |
Are health education effective to improve herpes zoster vaccine willingness in vulnerable elderly
|
Zhang, Xiyu
|
|
|
54 |
C |
p.
|
artikel
|
| 8 |
A review of Canadian online resources providing information on COVID-19 vaccination for caregivers of children aged 5–11 years
|
Di Chiara, Costanza
|
|
|
54 |
C |
p.
|
artikel
|
| 9 |
Assessment of recombinant Lactobacillus vector-based expressing IFITM3 protein anti-PRV infection in mice.
|
Zheng, Fan
|
|
|
54 |
C |
p.
|
artikel
|
| 10 |
Associated factors for dropout of first versus third doses of pentavalent vaccination in Tanzania
|
Tillya, Robert
|
|
|
54 |
C |
p.
|
artikel
|
| 11 |
Association of serum anti-gbs2106 protein immunoglobulin G (IgG) in newborns and risk reduction of invasive group B streptococcus disease during early infancy.
|
Gent, Vicky
|
|
|
54 |
C |
p.
|
artikel
|
| 12 |
Childhood vaccination coverages in rural Guinea-Bissau before and during the early COVID-19 pandemic, a cohort study
|
Vedel, Julie Odgaard
|
|
|
54 |
C |
p.
|
artikel
|
| 13 |
Collaborative influenza vaccine innovation centers (CIVICs) program
|
Singleton, Kentner L.
|
|
|
54 |
C |
p.
|
artikel
|
| 14 |
Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic
|
Fuji, Naoko
|
|
|
54 |
C |
p.
|
artikel
|
| 15 |
Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021–October 2023
|
Hamid, Sarah
|
|
|
54 |
C |
p.
|
artikel
|
| 16 |
Corrigendum to “Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)” [Vaccine 49 (7) (2025) 126815]
|
Ye, Qiang
|
|
|
54 |
C |
p.
|
artikel
|
| 17 |
Corrigendum to “Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurella multocida serogroups in mouse models” [Vaccine 42 (2024) 3075–3083]
|
Wang, Zihao
|
|
|
54 |
C |
p.
|
artikel
|
| 18 |
Corrigendum to “Knowledge, attitudes, and practices and long-term immune response after rVSVΔG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda” [Vaccine 24 (22) (2024) 126031]
|
Waltenburg, Michelle A.
|
|
|
54 |
C |
p.
|
artikel
|
| 19 |
Corrigendum to “Long-Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccine” [Vaccine, Volume 50, 19 March 2025, 126,817].
|
Carter, Joseph J.
|
|
|
54 |
C |
p.
|
artikel
|
| 20 |
Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in Canada
|
Ximenes, Raphael
|
|
|
54 |
C |
p.
|
artikel
|
| 21 |
Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A Meta-analysis of demographic and health survey reports between 2015 and 2025
|
Tamir, Tadesse Tarik
|
|
|
54 |
C |
p.
|
artikel
|
| 22 |
Development of broadly protective coronavirus vaccines: A joint NIAID-CEPI workshop report.
|
Gordon, Jennifer L.
|
|
|
54 |
C |
p.
|
artikel
|
| 23 |
Does Geoffrey Rose's legacy apply to immunisation strategies?
|
Vigezzi, Giacomo Pietro
|
|
|
54 |
C |
p.
|
artikel
|
| 24 |
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
|
Moore, Mia
|
|
|
54 |
C |
p.
|
artikel
|
| 25 |
Editorial Board
|
|
|
|
54 |
C |
p.
|
artikel
|
| 26 |
Effect of a proactive childhood vaccination reminder system on vaccination coverage and uptake in Denmark: A register-based cohort study
|
Funk, Tjede
|
|
|
54 |
C |
p.
|
artikel
|
| 27 |
Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis
|
de Souza, Ramon Andrade
|
|
|
54 |
C |
p.
|
artikel
|
| 28 |
Epidemiology and clinical burden of invasive pneumococcal disease in older adults in the city of São Paulo, Brazil
|
Jarovsky, Daniel
|
|
|
54 |
C |
p.
|
artikel
|
| 29 |
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination
|
Stoner, Marie C.D.
|
|
|
54 |
C |
p.
|
artikel
|
| 30 |
Evaluating the impact of influenza vaccine on preventing stroke hospitalization and death in Chinese elderly hypertensive patients: A retrospective cohort study
|
Tong, Feng
|
|
|
54 |
C |
p.
|
artikel
|
| 31 |
Evaluation of a DNA vector plasmid encoding a partial rop18 gene from toxoplasma gondii in domestic cats as a vaccine candidate
|
Minutti, Ana Flávia
|
|
|
54 |
C |
p.
|
artikel
|
| 32 |
Factors associated with influenza and COVID-19 vaccination among health workers in Lao PDR, 2023
|
Patthammavong, Chansay
|
|
|
54 |
C |
p.
|
artikel
|
| 33 |
Generative AI for vaccine misbelief correction: Insights from targeting extraversion and pseudoscientific beliefs
|
Lu, Hang
|
|
|
54 |
C |
p.
|
artikel
|
| 34 |
Health care institutions and their physicians are the greatest promoters of COVID-19 vaccine acceptance among health care workers
|
Ricci, Laetitia
|
|
|
54 |
C |
p.
|
artikel
|
| 35 |
Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional food markets in Bolivia (2020−2022): A cross-sectional analysis of a serological survey
|
Leyns, Christine
|
|
|
54 |
C |
p.
|
artikel
|
| 36 |
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial
|
Perez Marc, Gonzalo
|
|
|
54 |
C |
p.
|
artikel
|
| 37 |
Impact of electronic immunization registries and electronic logistics management information systems in four low-and middle-income countries: Guinea, Honduras, Rwanda, and Tanzania
|
Mantel, C.
|
|
|
54 |
C |
p.
|
artikel
|
| 38 |
Impact of novel Oral Poliovirus Type 2 vaccination campaigns: A seroprevalence survey in Nigeria, 2022
|
Iliyasu, Zubairu
|
|
|
54 |
C |
p.
|
artikel
|
| 39 |
Incorporating vaccines into vaccination schedules around the world: A scoping review
|
de Melo Araújo, Ana Catarina
|
|
|
54 |
C |
p.
|
artikel
|
| 40 |
Investigating the measles susceptibility gap in Ontario infants
|
Bolotin, Shelly
|
|
|
54 |
C |
p.
|
artikel
|
| 41 |
Knowledge-based mitigation of the environmental risk of Orthoflavivirus live-attenuated vaccines by targeting viral encoded determinants for the mosquito attenuated phenotype
|
Mantlo, Emily K.
|
|
|
54 |
C |
p.
|
artikel
|
| 42 |
Long-term effectiveness of vaccination for prevention of hepatitis B virus mother-to-child transmission in Yunnan, China
|
Wang, Feng
|
|
|
54 |
C |
p.
|
artikel
|
| 43 |
Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4–5 June 2024
|
Gharpure, Radhika
|
|
|
54 |
C |
p.
|
artikel
|
| 44 |
Meeting report: Expert consultation on late arresting replication competent (LARC) malaria sporozoite vaccine research & development
|
Mo, Annie X.
|
|
|
54 |
C |
p.
|
artikel
|
| 45 |
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice
|
Lee, Diana Wing
|
|
|
54 |
C |
p.
|
artikel
|
| 46 |
Nationwide population-based surveillance of invasive pneumococcal disease in children in Japan (2014–2022): Impact of 13-valent pneumococcal conjugate vaccine and COVID-19 pandemic
|
Takeuchi, Noriko
|
|
|
54 |
C |
p.
|
artikel
|
| 47 |
Next-generation seasonal influenza virus vaccines need a neuraminidase component
|
Krammer, Florian
|
|
|
54 |
C |
p.
|
artikel
|
| 48 |
Novel, fully human, anti-PfCSP antibodies with potent antimalarial activity using a phage display based strategy
|
Parveen, Sadaf
|
|
|
54 |
C |
p.
|
artikel
|
| 49 |
Opportunities and challenges for the adoption of novel platform technologies to develop veterinary bacterial vaccines
|
Entrican, Gary
|
|
|
54 |
C |
p.
|
artikel
|
| 50 |
Optimising human rabies vaccine supply chains: A modelling study
|
Luka, Martha M.
|
|
|
54 |
C |
p.
|
artikel
|
| 51 |
Pharmacy and healthcare provider offices as convenient adult vaccination settings in the US: Patient experiences from a survey of recently-vaccinated adults
|
La, Elizabeth M.
|
|
|
54 |
C |
p.
|
artikel
|
| 52 |
Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening
|
Yuill, Susan
|
|
|
54 |
C |
p.
|
artikel
|
| 53 |
Pregnant persons perceptions and uptake of prenatal RSV vaccine – Minnesota, 2023–2024
|
DeSilva, Malini B.
|
|
|
54 |
C |
p.
|
artikel
|
| 54 |
SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants.
|
Carroll, Melanie
|
|
|
54 |
C |
p.
|
artikel
|
| 55 |
Seasonal influenza vaccination in Kenya: What determines healthcare Workers' willingness to accept and recommend vaccination?
|
Otieno, Nancy A.
|
|
|
54 |
C |
p.
|
artikel
|
| 56 |
Sensitive detection of pertussis toxin in acellular pertussis vaccines using HRH1-mediated calcium signaling
|
Lee, Jin-Woo
|
|
|
54 |
C |
p.
|
artikel
|
| 57 |
Sociodemographic and health-related predictors of COVID-19 booster uptake among fully vaccinated adults
|
Tiruneh, Yordanos M.
|
|
|
54 |
C |
p.
|
artikel
|
| 58 |
Strengthening health security through routine vaccination policy: A comprehensive analysis of childhood vaccination laws across 194 countries
|
Weets, Ciara M.
|
|
|
54 |
C |
p.
|
artikel
|
| 59 |
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine
|
Myburgh, Lauren
|
|
|
54 |
C |
p.
|
artikel
|
| 60 |
The direct impact of mandatory PCV10 vaccination on invasive pneumococcal disease in Polish children
|
Skoczyńska, Anna
|
|
|
54 |
C |
p.
|
artikel
|
| 61 |
The global regulatory landscape for combined vaccines: A comparative case study of registration strategies for diphtheria-tetanus-pertussis-containing vaccines.
|
He, Xiangchuan
|
|
|
54 |
C |
p.
|
artikel
|
| 62 |
The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States
|
Arsenault, Catherine
|
|
|
54 |
C |
p.
|
artikel
|
| 63 |
The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype
|
Navaeiseddighi, Zahrasadat
|
|
|
54 |
C |
p.
|
artikel
|
| 64 |
Uptake and determinants of routine immunization among vulnerable children and adolescents in sub-Saharan Africa: A scoping review
|
Chege, Christine Karanja
|
|
|
54 |
C |
p.
|
artikel
|
Tijdschrift beschrijving